Evidence map›Paper›PMID 42244318›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026

[Application of puncture tissue rinse solution in the detection of

Hui Xiong, Weini Quan, Ping Liu, Yuanqiang Wu, Zhenhua Qiu, Xiaokang Xiang, Miao Yan, Jin'an Ma

Abstract readEnglish Abstract
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hui XiongDepartment of Oncology, Second Xiangya Hospital, Central South University, Changsha 410011. xh7902@163.com.
Weini QuanDepartment of Oncology, Second Xiangya Hospital, Central South University, Changsha 410011. quanweini1123@163.com.
Ping LiuDepartment of Oncology, Second Xiangya Hospital, Central South University, Changsha 410011.
Yuanqiang WuDepartment of Oncology, Second Xiangya Hospital, Central South University, Changsha 410011.
Zhenhua QiuDepartment of Oncology, Second Xiangya Hospital, Central South University, Changsha 410011.
Xiaokang XiangDepartment of Oncology, Second Xiangya Hospital, Central South University, Changsha 410011.
Miao YanDepartment of Pharmacy, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Jin'an MaDepartment of Oncology, Second Xiangya Hospital, Central South University, Changsha 410011. majinancs@csu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPrecision targeted therapy for non-small cell lung cancer (NSCLC) relies on molecular classification based on gene mutations. Detection of driver gene mutations, particularly epidermal growth factor receptor (EGFR) mutations, is crucial for treatment decision-making in locally advanced and metastatic NSCLC. Currently, clinical sources of nucleic acids include formalin-fixed paraffin-embedded (FFPE) tumor tissues, cytological specimens from centrifuged pleural effusion, blood, and circulating free DNA in body fluids such as pleural effusion supernatant. This study aims to extract nucleic acids from the double-distilled water rinse solution of lung biopsy specimens for gene mutation detection, to evaluate the feasibility of this nucleic acid source, and to analyze the concordance between its detection results and those obtained from tissue-based next-generation sequencing (NGS), thereby providing a basis for subsequent pathological diagnosis and treatment.

methodsFemale patients clinically diagnosed with NSCLC and admitted to the Department of Oncology, the Second Xiangya Hospital of Central South University were included. CT-guided percutaneous lung biopsy was performed. Biopsy tissues were processed into paraffin-embedded sections for NGS testing. Meanwhile, DNA was extracted from the double-distilled water rinse solution of biopsy tissues, and EGFR gene mutations were detected using the super amplification refractory mutation system-polymerase chain reaction (Super-ARMS). Samples with remaining DNA meeting quality control standards were further subjected to NGS. The concordance between gene mutation results from the rinse solution and those from corresponding FFPE tissue samples was analyzed. In addition, DNA concentrations from percutaneous biopsy specimens and from the rinse solution of the puncture needle were measured and compared.

resultsAmong 29 NSCLC patients, Super-ARMS of the biopsy tissue rinse solution detected 19

conclusionsTDNA extracted from the double-distilled water rinse solution of CT-guided percutaneous lung biopsy specimens can serve as a rapid and efficient nucleic acid source for NSCLC genotyping, enabling earlier support for clinical diagnosis and treatment.

Indexed as

Carcinoma, Non-Small-Cell LungErbB ReceptorsLung NeoplasmsMutationDNA Mutational AnalysisFemaleHigh-Throughput Nucleotide SequencingHumansMiddle AgedEGFR protein, humanErbB ReceptorsbiopsyEGFR gene mutation detectionnon-small cell lung cancernucleic acid sourcepuncture tissue rinse solution

Identifiers

PMID42244318
PMCPMC13229659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.